Zilia Inc. | Non-invasive, quantitative measurement of ocular oxygen saturation | Micron, Inc.

Zilia Inc. | Non-invasive, quantitative measurement of ocular oxygen saturation

Brief Product Description
Non-invasive, quantitative measurement of ocular oxygen saturation

Brief Product Description
Ophthalmology: Glaucoma, diabetic retinopathy, age-related macular degeneration (AMD)
Neurology: Parkinson’s disease
Cardiology: Cardiac amyloidosis (ATTR-CM)

A multimodal platform combining retinal imaging, spectroscopy, and artificial intelligence (AI) for the non-invasive, quantitative measurement of ocular oxygen saturation, a functional and metabolic biomarker previously inaccessible in clinical practice.

Company

This field is for validation purposes and should be left unchanged.

Your NameRequired

Email AddressRequired

*If you have set up domain rejection, please check your email receiving settings to allow emails from [@micron-kobe.com].

Company / OrganizationRequired

Department / Faculty NameRequired

Position

Phone Number

Purpose

Inquiry Details

Micron Updates

I would like to receive updates from Micron.

Notes on Contact Form

ConfirmationRequired

I agree to the above notes and confirm that I have reviewed the contents of this form.

Please feel free to contact us

We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.

With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.

Downloads